Galidesivir is an adenosine analogue that has been investigated for use against Zaire Ebolavirus. In animal studies, galidesivir was effective in increasing the survival rates from infections caused by various pathogens, including Ebola, Marburg, Yellow Fever and Zika viruses. Phase 1 clinical trials have begun to determine the safety of this drug in humans. Because of its activity against other coronaviruses, it may be studied as a potential therapy for COVID-19.
This report contains market size and forecasts of Galidesivir in Global, including the following market information:
Global Galidesivir Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Galidesivir market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Galidesivir Powder Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Galidesivir include BioCryst Pharmaceuticals, ChemScene, Taiclone, CliniSciences, Xi'an Henrikang Biotech Co. and Cayman Chemical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Galidesivir companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Galidesivir Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Galidesivir Market Segment Percentages, by Type, 2021 (%)
Galidesivir Powder
Galidesivir Hydrochloride
Global Galidesivir Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Galidesivir Market Segment Percentages, by Application, 2021 (%)
Marburg Virus Disease
Filovirus Infections/Ebola Virus Infection
Yellow Fever
Global Galidesivir Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Galidesivir Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Galidesivir revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Galidesivir revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
BioCryst Pharmaceuticals
ChemScene
Taiclone
CliniSciences
Xi'an Henrikang Biotech Co.
Cayman Chemical